Loading organizations...
Harbor Street Ventures is a Chicago, Illinois-based family office that invests in early-stage companies, primarily within the healthcare sector. The firm operates by deploying its own capital, focusing on identifying and supporting innovative ventures across health technology, medical devices, and life sciences. While specific details regarding its assets under management, portfolio company valuations, or lead investors are not publicly disclosed, Harbor Street Ventures strategically deploys capital to foster growth in its target market. Its investment strategy emphasizes long-term partnerships with promising startups, typically engaging with companies in their seed to Series A funding rounds and providing strategic guidance. The firm seeks to leverage its expertise to guide portfolio companies through critical development phases, aiming for significant impact within the evolving healthcare landscape. Led by its founder and managing director, Steve Komie, Harbor Street Ventures was established in 2014.
Harbor Street Ventures has 2 tracked investments across 2 companies. The latest tracked deal is $1.5M Seed in Enzee Health in September 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 14, 2022 | Enzee Health | $1.5M Seed | Ryan Helon | M7 NEO, Redgrave Investments, Service Provider Capital, Mark Shary |
| Jun 27, 2019 | C2RO | $1.7M Other Equity | Richard Bordeleau | GCI Capital, Ministère DE L'économie, DE L'innovation ET DE L'énergie, TandemLaunch |